Pharmaceuticals

Asymchem

Asymchem Tianjin to convene 2nd H-share AGM on June 10 to vote on A-share buyback authorization

Citi Group Reduced Its Holding of KaiLaiIn H Shares

JPMorgan Reduces Long Position in Kerry Logistics Shares

Caillyang 2026 Q1 Financial Report Analysis and Target Price Release

Schroders PLC Reduces Holding of KaiLuePharmaceutical to 538.03W Shares

Norges Bank Reduced holdings of KaiZeYing By 184,900 Shares

CMBI Raises Kaiwen's Target Price and Investment Rating

Catalyst Inc's Q1 net profit down by 6.82%

Asymchem released FY2026 Q1 earnings on April 27 Pre-Market (BJT), actual revenue HKD 2.043 B (forecast HKD 1.977 B), actual EPS HKD 0.9523

Norges Bank increases holdings in KaiLueYing by 85,300 shares

Asymchem FY2026 Q1 Earnings Release on April 27 Pre-Market (BJT), Forecast Revenue HKD 1.977 B

CMBC International Reiterates Buy Rating on KaiLuePharm's H Shares

JPMorgan 增持凯莱英股票至 8.26%

Norges Bank reduces holdings in KaiLueE 263,200 shares

Kaleido Life Sciences Projects 19%-22% Revenue Growth in 2026

CMBI Raises Kaiwen's Target Price to HKD 123.2 and Maintains Buy Rating

凯莱英 Releases 2025 Annual Performance Report

Catalyst Biosciences' Net Profit Increased by 19.4% in 2025

Asymchem released FY2025 earnings on March 30 After-Market (BJT), actual revenue HKD 7.29 B (forecast HKD 7.425 B), actual EPS HKD 3.4537 (forecast HKD 3.5624)

Asymchem released FY2025 Q4 earnings on March 30 After-Market (BJT), actual revenue HKD 2.269 B (forecast HKD 2.252 B), actual EPS HKD 1.1118

HINSANG GROUP

RIVERINE CHINA

PASHUN INT RTS

BRAINAURORA-B

SOFTMEDX

GOLDENPOWER

ZHONGKE GROUP

VISION SYNERGY

GEMILANG INTL

GHPC

06821

BOCOM International Holdings Company analyst maintained a Buy rating on Asymchem Laboratories (Tianjin) Co., Ltd. Class H yesterday and set a price target of HK$136.60.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Asymchem Laboratories (Tianjin) Co., Ltd. Class H has an analyst consensus of Strong Buy, with a price target consensus of HK$126.91.

Tip Ranks

BOCOM INTL

BOCOM International Holdings Company Reaffirms Their Buy Rating on Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821)

Today, Asymchem's trading volume was approximately HKD 105 million, with overall trading being relatively light. However, bullish signals have begun to emerge on the daily MACD level, suggesting that the short-selling pressure accumulated during the previous continuous pullback is starting to weaken marginally. Asymchem's stock price has been fluctuating in the low range recently, with short-term moving averages tending to flatten, and the balance of bullish and bearish forces is gradually stabilizing. The emergence of this bullish signal typically indicates that the market is brewing a directional choice, increasing the possibility of a phase bottom formation. On the news front, the recovery pace of the CXO industry is one of the current market focuses. Global investment in innovative drug research and development continues to grow, and the outsourcing demand from large multinational pharmaceutical companies is gradually warming up, providing support for orders to CDMO companies like Asymchem. However, the Federal Reserve's decision to maintain interest rates in April's FOMC meeting and its hawkish stance make it difficult for the global biopharmaceutical financing environment to significantly loosen in the short term, and the R&D outsourcing budgets of early biotech companies may continue to be suppressed. In terms of sectors, WuXi AppTec fell 3.7% today, and the weakness of the CXO sector leader has created some drag on sector sentiment. It remains to be seen whether Asymchem can independently rebound. From a technical perspective, Asymchem's current trading volume is low, and the HKD 105 million trading volume is insufficient to support a significant rebound. The reliability of bullish signals in a low-volume environment is relatively limited, and it will be necessary to observe whether there is a gentle increase in volume to accompany it. If the CXO sector leader stabilizes and rebounds first, Asymchem, as a quality target within the sector, is expected to benefit from a follow-on effect of funds

Technical Forecast

WUXI APPTEC

WuXi AppTec

Pre-market trend | Asymchem (6821.HK) shows bullish signs with reduced volume consolidation on 4/29, can the CXO sector recover?

02359

G Sachs' report on the mainland CDMO sector indicates resilience, with earnings visibility linked to late-stage projects. AI has not disrupted order volumes or pricing. The bank favors stocks like Wuxi AppTec and Asymchem, upgrading AK Medical and MicroTech Medical, while downgrading Weigao Group and Topchoice Medical due to margin pressures and uncertain growth. Overall, the report highlights a mixed recovery in the medical device and healthcare service sectors.

AASTOCKS News

Goldman Sachs

MircroPort Medbot-B

EDGE MEDICAL-B

AK MEDICAL

MICROTECH MED-B

WEIGAO GROUP

TC Medical

GS Hldg R

G Sachs: Mainland CDMO Sector Remains Resilient, Favors Wuxi AppTec , Asymchem  and Others

CMBC International has reaffirmed a Buy rating on Asymchem Laboratories (Tianjin) Co., Ltd. Class H, setting a price target of HK$135.59. The shares closed at HK$98.45. The analyst consensus for the company is a Strong Buy, with an average price target of HK$123.56.

MINSHENG BANK

CMBC

CMBC International Reaffirms Their Buy Rating on Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821)

002821

520880

In Tianjin, China, on April 14, 2026, Asymchem, a leading global contract development and manufacturing organization (CDMO), introduced a comprehensive commercial supply framework for TIDES (Peptides and Oligonucleotides) at its TJ4 facility. This initiative merges increased API manufacturing capabilities.

Unusual Whales

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

China Merchants CSI Biotechnology Theme ETF

Yinhua CSI Innovative Drugs Industry ETF

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)

ChinaAMC SSE Health Care ETF Initiating Fund

E Fund Hang Seng SCHK Innovative Drug ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

ChinaAMC SSE STAR Biology and Medicine ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Minsheng Royal CSI Biotechnology Theme ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

E Fund CSI Biotechnology Theme ETF

ChinaAMC CSI Biotechnology Theme ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

First Trust NYSE Arca Biotech Index Fd

China Universal CNI HK Connect Innovative Drugs Industry ETF

Guotai CSI Bio-medicine ETF

Hwabao WP CSI Pharmaceuticals ETF

Bosera Hang Seng Health Care ETF(QDII)

E Fund CSI 300 Health Care ETF

Asymchem Unveils Its Fully Integrated TIDES Commercial Supply Matrix - Supporting Partners from Molecule to Market

02656

00568

03668

01921

02025

02632

01530

03378

01579

160 HEALTH(02656) fell 32.4%, with a trading turnover 126.5 Million HKD, and a year-to-date rose 22.9%. SHANDONG MOLONG(00568) fell 12.99%, with a trading turnover 1.2 Billion HKD, and a year-to-date rose 153.6%. YANCOAL AUS(03668) fell 8.4%, with a trading turnover 291.2 Million HKD, and a year-to-date rose 64.3%.

Top Gainers&Losers

160 HEALTH

SHANDONG MOLONG

YANCOAL AUS

DALIPAL HLDG

RUIFENG POWER

NEW VISION CO

3SBIO

HANXBIO-B

YIHAI INTL

Top 10 HK Stock Losers (4.8)

BOCOM International Holdings Company has maintained a Buy rating on Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821), setting a price target of HK$123.20. Additionally, TipRanks also issued a Buy rating for the company, while another report from TipRanks reiterated a Hold rating on the same day.

Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) Gets a Buy from BOCOM International Holdings Company

002361

000550

600066

The automotive vehicle sector showed strength, with the bus segment leading the gains. Yutong Bus and SG Automotive Group both hit the daily limit, while Zhongtong Bus Holding Co.,LTD, KLM, JMC, and Ankai saw significant increases. The commercial aerospace concept continued its strong performance, with SHENJIAN GUFEN up for 4 consecutive trading days, followed by SHUNHO STOCK, Shaoyang Hydraulic, Zhongheng Design, Jullyar, and Chaojie Precision.
Innovative drug stocks were repeatedly active, with TJPC up for 3 consecutive trading days, followed by Asymchem, Biosan, Pharmaron, HITECK, and Novus Therapeutics

- On March 31, A-shares experienced fluctuations, with the Shanghai index rising by 0.45%, while the ChiNext index fell by 0.41%.  
- Hong Kong stocks opened strong but narrowed their gains, with the Hang Seng index up 0.15%.  
- The bond market showed mixed results, and commodity futures mostly declined, although metals like silver and gold increased.

Wallstreetcn

SHENJIAN GUFEN

HITECK

SHUNHO STOCK

Ankai

SG AUTOMOTIVE GROUP

PHARMARON

TJPC

Zhongtong Bus Holding Co.,LTD

Pharmaron

YTCO

Shanghai Composite Index Volatile Up, Innovative Drugs and Auto Stocks Rally Mid-day, Commercial Aerospace Active, Hang Seng Tech Index Surges and Falls Back, Tech Stocks Diverge

00658

02665

01872

02889

06687

02609

01519

01415

00290

C TRANSMISSION(00658) rose 31.76%, with a trading turnover 11.4 Million HKD, and a year-to-date rose 19.6%. SEYOND(02665) rose 28.25%, with a trading turnover 107.5 Million HKD, and a year-to-date fell 9%. GUAN CHAO HLDGS(01872) rose 19.86%, with a trading turnover 25.2 Million HKD, and a year-to-date fell 5.8%.

C TRANSMISSION

SEYOND

GUAN CHAO HLDGS

PATEO

JST GROUP

BAYZED HEALTH

J&T EXPRESS-W

COWELL

GOFINTECH QUANT

Top 10 HK Stock Gainers (3.31)

399006

000333

000688

399002

601699

399102

399001

36Kr learned that the three major A-share indices collectively closed lower, with the Shanghai Composite Index down 0.8%, the Shenzhen Component Index down 1.81%, and the ChiNext down 2.7%; CPO, lithium mining, and coal stocks led the decline, with Dekor falling over 10%, Guocheng Mining down over 8%, and Lu'an EED down over 6%; the automotive, CRO, and home appliance sectors saw significant gains, with YTCO and Asymchem hitting the daily limit, and Midea Group rising over 5%

36Kr

ChiNext

Midea Group

Guocheng Mining

Shenzhen TRI

Lu′an EED

ChiNext Composite

Shenzhen Index

The three major A-share indices collectively closed lower, and the CPO concept declined

Asymchem(06821.HK)